statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
VINC stock results show that Vincerx Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.
The post VINC...

VINC Stock Earnings: Vincerx Pharma Beats EPS for Q4 2023

Vincerx to also provide update on pipeline progress, including for VIP943 programPALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical...

Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

Vincerx Pharma GAAP EPS of -$0.23 beats by $0.06...

Vincerx Pharma GAAP EPS of -$0.23 beats by $0.06

Comparing Vincerx Pharma's Performance Against Analyst EstimatesRelated Stocks: VINC...

Vincerx Pharma Inc (VINC) Reports Q4 and Full Year 2023 Financials: A Close Look

VIP236, first-in-class small molecule-drug conjugate (SMDC), preliminary Phase 1 data and update on pipeline progress will be presented by management at a virtual investor event on April 8 at 2:00 PM...

Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

Over the last three days, A.I.dvisor has detected that VINC's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Vincerx Pharma (VINC, $6.7) Aroon Indicator entered an Uptrend on March 20, 2024.

Vincerx Pharma (VINC, $6.3) Aroon Indicator entered an Uptrend on March 19, 2024.

Vincerx Pharma (VINC, $4.91) Aroon Indicator entered an Uptrend on March 18, 2024.

Vincerx Pharma (VINC, $5.55) Aroon Indicator entered an Uptrend on March 15, 2024.

Vincerx Pharma (VINC, $5.99) Aroon Indicator entered an Uptrend on March 14, 2024.

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The firm pipeline is derived from a license agreement with Bayer and includes: a clinical-stage and follow-on small molecule drug program and preclinical stage bioconjugation/next-generation antibody-drug conjugate platform. The company was founded by Ahmed M. Hamdy, Raquel E. Izumi, Tom C. Thomas, Soo In Hwang and John C. Byrd on December 19, 2018 and is headquartered in Palo Alto, CA.

Vincerx Pharma Inc

Volume	500,821.00
52-Wk High	$9.37
52-Wk Low	$0.61

VINC Vincerx Pharma Inc

About

Feed

News

Sentiment

Fundamentals